Global Hereditary Cancer Testing Market Trend, Share, Growth, Size, Analysis and Forecast 2032
Hereditary Cancer Testing Market by Diagnosis Type (Biopsy, Imaging and Others), By End-User (Hospitals, Clinics, and Diagnostic Centers), and by Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 5.97 Billion | USD 11.44 Billion | 7.5% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Hereditary Cancer Testing Market, 2015 - 2024 (USD Billion)
- 2.2. Global Hereditary Cancer Testing Market: Snapshot
- Chapter 3. Hereditary Cancer Testing Market Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global Hereditary Cancer Testing Market drivers: Impact analysis
- 3.2.2. Swelling demand for non-invasive techniques for detection of hereditary cancer
- 3.2.3. Increasing government funding for improvement of rapid diagnostics
- 3.3. Market Restraints
- 3.3.1. Difficulties in accessing the complete genomic data for early detection and prevention
- 3.4. Opportunities
- 3.4.1. Inevitable need of avoiding cancer
- 3.5. Porter's five forces analysis
- 3.5.1. Bargaining power of suppliers
- 3.5.2. Bargaining power of buyers
- 3.5.3. Threat from new entrants
- 3.5.4. Threat from new substitutes
- 3.5.5. Degree of competition
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by Diagnosis Type
- 3.6.2. Market attractiveness analysis, by End-User
- 3.6.3. Market attractiveness analysis, by Regional Segment
- Chapter 4. Global Hereditary Cancer Testing Market - Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global Hereditary Cancer Testing Market: company market share, 2015
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Diagnosis Type Launch
- 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
- 4.2.4. Research and Development, Regional Expansion
- 4.1. Company Market Share Analysis
- Chapter 5. Global Hereditary Cancer Testing Market - Diagnosis Type Segment Analysis
- 5.1. Global Hereditary Cancer Testing Market: Diagnosis Type overview
- 5.1.1. Global Hereditary Cancer Testing Market revenue share, by Diagnosis Type, 2015 and 2024(USD Billion)
- 5.2. Biopsy
- 5.2.1. Global Biopsy market, 2015 - 2024(USD Billion)
- 5.3. Imaging
- 5.3.1. Global Imaging market, 2015 - 2024(USD Billion)
- 5.4. Others
- 5.4.1. Global Others market, 2015 - 2024(USD Billion)
- 5.1. Global Hereditary Cancer Testing Market: Diagnosis Type overview
- Chapter 6. Global Hereditary Cancer Testing Market - End-User Channel Segment Analysis
- 6.1. Global Hereditary Cancer Testing Market: End-User Channel overview
- 6.1.1. Global Hereditary Cancer Testing Market revenue share, by End-User Channel, 2014 and 2024(USD Billion)
- 6.2. Hospitals
- 6.2.1. Global Hereditary Cancer Testing Market for Hospitals, 2015 - 2024(USD Billion)
- 6.3. Clinics
- 6.3.1. Global Hereditary Cancer Testing Market for Clinics, 2015 - 2024(USD Billion)
- 6.4. Diagnostic Centers
- 6.4.1. Global Hereditary Cancer Testing Market for Diagnostic Centers, 2015 - 2024(USD Billion)
- 6.1. Global Hereditary Cancer Testing Market: End-User Channel overview
- Chapter 7. Global Hereditary Cancer Testing Market - Regional Segment Analysis
- 7.1. Global Hereditary Cancer Testing Market: Regional overview
- 7.1.1. Global Hereditary Cancer Testing Market revenue share, by Region, 2015 and 2024
- 7.2. North America
- 7.2.1. North America Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.2.2. North America Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.2.3. North America Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
- 7.2.4. The U.S.
- 7.2.4.1. The U.S. Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.2.4.2. The U.S. Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.2.4.3. The U.S. Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
- 7.2.5. Rest of North America
- 7.2.5.1. Rest of North America Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.2.5.2. Rest of North America Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.2.5.3. Rest of North America Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
- 7.3. Europe
- 7.3.1. Europe Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.3.2. Europe Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.3.3. Europe Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
- 7.3.4. Germany
- 7.3.4.1. Germany Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.3.4.2. Germany Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.3.4.3. Germany Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
- 7.3.5. U.K.
- 7.3.5.1. U.K. Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.3.5.2. U.K. Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.3.5.3. U.K. Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
- 7.3.6. France
- 7.3.6.1. France Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.3.6.2. France Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.3.6.3. France Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
- 7.3.7. Rest of Europe
- 7.3.7.1. Rest of Europe Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.3.7.2. Rest of Europe Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.3.7.3. Rest of Europe Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.4.2. Asia Pacific Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.4.3. Asia Pacific Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
- 7.4.4. China
- 7.4.4.1. China Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.4.4.2. China Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.4.4.3. China Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
- 7.4.5. Japan
- 7.4.5.1. Japan Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.4.5.2. Japan Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.4.5.3. Japan Hereditary Cancer Testing Market revenue, by region, 2015 - 2024(USD Billion)
- 7.4.6. India
- 7.4.6.1. India Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.4.6.2. India Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.4.6.3. India Hereditary Cancer Testing Market revenue, by region, 2015 - 2024(USD Billion)
- 7.4.7. Rest of Asia Pacific
- 7.4.7.1. Rest of Asia Pacific Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.4.7.2. Rest of Asia Pacific Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.4.7.3. Rest of Asia Pacific Hereditary Cancer Testing Market revenue, by region, 2015 - 2024(USD Billion)
- 7.5. Latin America
- 7.5.1. Latin America Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.5.2. Latin America Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.5.3. Latin America Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
- 7.5.4. Brazil
- 7.5.4.1. Brazil Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.5.4.2. Brazil Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.5.4.3. Brazil Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
- 7.5.5. Rest of Latin America
- 7.5.5.1. Rest of Latin America Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.5.5.2. Rest of Latin America Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.5.5.3. Rest of Latin America Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
- 7.6. The Middle East and Africa
- 7.6.1. The Middle East and Africa Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 - 2024(USD Billion)
- 7.6.2. The Middle East and Africa Hereditary Cancer Testing Market revenue, by End-User, 2015 - 2024(USD Billion)
- 7.6.3. The Middle East and Africa Hereditary Cancer Testing Market Revenue, by Region, 2015 - 2024(USD Billion)
- 7.1. Global Hereditary Cancer Testing Market: Regional overview
- Chapter 8. Company Profile
- 8.1. Myriad Genetic
- 8.1.1. Overview
- 8.1.2. Financials
- 8.1.3. Therapy portfolio
- 8.1.4. Business strategy
- 8.1.5. Recent developments
- 8.2. Myogenes
- 8.2.1. Overview
- 8.2.2. Financials
- 8.2.3. Therapy portfolio
- 8.2.4. Business strategy
- 8.2.5. Recent developments
- 8.3. Laboratory Corporation of America
- 8.3.1. Overview
- 8.3.2. Financials
- 8.3.3. Therapy portfolio
- 8.3.4. Business strategy
- 8.3.5. Recent developments
- 8.4. Biocartis NV
- 8.4.1. Overview
- 8.4.2. Financials
- 8.4.3. Therapy portfolio
- 8.4.4. Business strategy
- 8.4.5. Recent developments
- 8.5. Quest Diagnostics
- 8.5.1. Overview
- 8.5.2. Financials
- 8.5.3. Therapy portfolio
- 8.5.4. Business strategy
- 8.5.5. Recent developments
- 8.6. Pathway Genomics
- 8.6.1. Overview
- 8.6.2. Financials
- 8.6.3. Therapy portfolio
- 8.6.4. Business strategy
- 8.6.5. Recent developments
- 8.7. Invitae Corporation
- 8.7.1. Overview
- 8.7.2. Financials
- 8.7.3. Therapy portfolio
- 8.7.4. Business strategy
- 8.7.5. Recent developments
- 8.8. Strand Life Sciences Pvt. Ltd.
- 8.8.1. Overview
- 8.8.2. Financials
- 8.8.3. Therapy portfolio
- 8.8.4. Business strategy
- 8.8.5. Recent developments
- 8.1. Myriad Genetic
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Hereditary Cancer Testing Market revenue, 2015 – 2024 (USD Billion)
4. Porter’s five forces analysis
5. Hereditary Cancer Testing Market attractiveness analysis, by Diagnosis Type segment
6. Hereditary Cancer Testing Market attractiveness analysis, by End-User segment
7. Hereditary Cancer Testing Market: Market attractiveness analysis, by regional segment
8. Company market share analysis, 2015
9. Global Hereditary Cancer Testing Market revenue share by Diagnosis Type, 2014 and 2022
10. Global Hereditary Cancer Testing Market, 2015 – 2024 (USD Billion)
- a. Global Biopsy market, 2015 – 2024(USD Billion)
- b. Global Imaging market, 2015 – 2024(USD Billion)
- c. Global Others market, 2015 – 2024(USD Billion)
11. Global Hereditary Cancer Testing Market revenue share by End-User, 2014 and 2022
12. Global Hereditary Cancer Testing Market, 2015 – 2024 (USD Billion)
- a. Hospitals, 2015 – 2024(USD Billion)
- b. Clinics, 2015 – 2024(USD Billion)
- c. Diagnostic Centers, 2015 – 2024(USD Billion)
Table Of Tables
List of Tables
1. Hereditary Cancer Testing Market: Market snapshot
2. Drivers of global Hereditary Cancer Testing Market: Impact analysis
3. Restraints of Hereditary Cancer Testing Market: Impact analysis
4. North America Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
5. North America Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
6. North America Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
7. The U.S. Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
8. The U.S. Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
9. The U.S. Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
10. Rest of North America Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
11. Rest of North America Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
12. Rest of North America Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
13. Europe Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
14. Europe Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
15. Europe Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
16. Germany Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
17. Germany Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
18. Germany Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
19. U.K. Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
20. U.K. Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
21. U.K. Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
22. France Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
23. France Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
24. France Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
25. Rest of Europe Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
26. Rest of Europe Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
27. Rest of Europe Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
28. Asia Pacific Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
29. Asia Pacific Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
30. Asia Pacific Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
31. China Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
32. China Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
33. China Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
34. Japan Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
35. Japan Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
36. Japan Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
37. India Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
38. India Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
39. India Hereditary Cancer Testing Market revenue, by region, 2015 – 2024(USD Billion)
40. Rest of Asia Pacific Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
41. Rest of Asia Pacific Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
42. Rest of Asia Pacific Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
43. Latin America Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
44. Latin America Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
45. Latin America Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
46. Brazil Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
47. Brazil Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
48. Brazil Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
49. Rest of Latin America Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
50. Rest of Latin America Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
51. Rest of Latin America Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
52. The Middle East and Africa Hereditary Cancer Testing Market revenue, by Diagnosis Type, 2015 – 2024(USD Billion)
53. The Middle East and Africa Hereditary Cancer Testing Market revenue, by End-User, 2015 – 2024(USD Billion)
54. The Middle East and Africa Hereditary Cancer Testing Market revenue, by Region, 2015 – 2024(USD Billion)
Methodology
FrequentlyAsked Questions
Hereditary cancer testing identifies genetic mutations linked to cancer risk. It helps in early detection and preventive care.
The global hereditary cancer testing market is expected to be driven by the genetic screening awareness, personalized medicine adoption, and advances in molecular diagnostics.
According to study, the global hereditary cancer testing market size was worth around USD 5.97 Billion in 2023 and is predicted to grow to around USD 11.44 Billion By 2032.
The global hereditary cancer testing market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 7.5% during the forecast period from 2024-2032.
The global hereditary cancer testing industry is projected to be challenged by Challenges include interpretation of genetic variants, data privacy concerns, and regulatory compliance. Limited awareness and reimbursement uncertainty affect testing uptake.
The Opportunities lie in genetic screening programs, precision oncology, and consumer genomics. Falling sequencing costs and awareness fuel test adoption will offer significant growth opportunities in the hereditary cancer testing market.
NGS-based multigene panels; AI-driven risk interpretation; expanding preventive and early-detection programs are the emerging trends and innovations impacting the hereditary cancer testing market.
The global hereditary cancer testing market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global hereditary cancer testing market are; Myriad Genetics, Myogenes, Laboratory Corporation of America, Biocartis NV, Quest Diagnostics, Pathway Genomics, Invitae Corporation, and Strand Life Sciences Pvt. Ltd., among others. and others.
The report explores crucial aspects of the hereditary cancer testing market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
